Mesoporous silicon: A platform for the delivery of therapeutics

Expert Opinion on Drug Delivery

Volumn 4, Issue 2, 2007, Pages 101-110

  Prestidge, Clive A ^a   Barnes, Timothy J ^a   Lau, Chi Hian ^b   Barnett, Christian ^b   Loni, Armando ^b   Canham, Leigh ^b  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^b pSiMedica Ltd   (United Kingdom)

Author keywords

Drug delivery; Nanostructuring; Porous silicon

Indexed keywords

ANTINEOPLASTIC AGENT; CHLORAMBUCIL; CYCLODEXTRIN DERIVATIVE; CYCLOSPORIN A; CYTOTOXIC AGENT; DEXAMETHASONE; DOXORUBICIN; HUMAN SERUM ALBUMIN; IBUPROFEN; INDOMETACIN; INSULIN; ITRACONAZOLE; LIPID; NANOCRYSTAL; NANOMATERIAL; PACLITAXEL; PEPTIDE DERIVATIVE; PHENAZONE; POLY(3 HYDROXYBUTYRIC ACID); POLYCAPROLACTONE; POLYGLACTIN; POLYLACTIC ACID; POLYMER; PROTEIN DERIVATIVE; SILICON; TAMOXIFEN;

BIOCOMPATIBILITY; BIODEGRADATION; BODY FLUID; CHEMICAL STRUCTURE; CONTROLLED DRUG RELEASE; DISSOLUTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG SOLUBILITY; ELECTROCHEMICAL ANALYSIS; FOREIGN BODY; HUMAN; HYDROLYSIS; HYDROPHILICITY; HYDROPHOBICITY; IMPLANT; NONHUMAN; PARTICLE SIZE; POROSITY; REVIEW; TISSUE ENGINEERING; TOXICITY TESTING;

CHEMISTRY, PHARMACEUTICAL; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; MATERIALS TESTING; NANOSTRUCTURES; NANOTECHNOLOGY; PEPTIDES; PHARMACEUTICAL PREPARATIONS; POROSITY; PROTEINS; SEMICONDUCTORS; SILICON;

EID: 33847783470     PISSN: 17425247     EISSN: None     Source Type: Journal    
DOI: 10.1517/17425247.4.2.101     Document Type: Review

References (66)

1. FERRARI M: Cancer nanotechnology: opportunities and challenges. Nat. Rev. Cancer (2005) 5:161-171.
2. UHLIR A: Electrolytic shaping of germanium and silicon. Bell Syst. Tech J. (1956) 35:333-347.
3. CANHAM LT: Bioactive silicon structure fabrication through nanoetching techniques. Adv. Mater. (1995) 7:1033-1035.
4. JANSHOFF A, DANCIL KPS, STEINEM C et al.: Macroporous p-type silicon fabry-perot layers. Fabrication, characterizarion and applications in biosensing. J. Am. Chem. Soc. (1998) 120:12108-12116
5. DROTT J, ROSENGREN L, LINDSTRÖM K, LAURELL T: Pore morphology influence on catalytic turn-over for enzyme activated porous silicon matrices. Thin Solid Films (1998) 330:161-166.
6. KOTZAR G, FREAS M, ABEL P et al.: Evaluation of MEMS materials of construction for implantable medical devices. Biomaterials (2002) 23:2737-2750.
7. ZHANG K, LOONG SL, CONNOR S et al.: Complete tumor response following intratumoral 32P BioSilicon on human hepatocellular and pancreatic carcinoma xenografts in nude mice. Clin. Cancer Res. (2005) 11(20):7532-7537.
8. GOH AS, CHUNG AY, LO RH et al.: A novel approach to brachytherapy in hepatocellular carcinoma using a phosphorus 32 brachytherapy delivery device - a first-in-man study. Int. J. Radiat. Oncol. Biol. Phys. (2006) 67(3):786-792
9. LEHMANN V: Electrochemistry of Silicon. Wiley-VCH (2002):51-75
10. YONEHARA T: Epitaxial layer transfer by bond and etch back of porous silicon Appl. Phys. Lett. (1994) 64(16):2108-2110.
11. KOLASINSKI K: Silicon nanostructures from electroless electrochemical etching. Current Opinion in Solid State and Materials Science (2005) 9:73-83.
12. ASHRUF CMA, FRENCH PJ BRESSERS PMMC, KELLY JJ: Galvanic porous silicon formation without external contacts. Sens. Actuators A Phys. (1999) 74:118-122.
13. CULLIS AG, CANHAM LT, CALCOTT PDJ: The structural and luminescence properties of porous silicon. J. Appl. Phys (1997) 82(3):909-965.
14. BISI O, OSSICINI S, PAVESI L: Porous silicon: a quantum sponge for silicon based optoelectronics. Surf. Sci. Reports (2000) 38(1-3):1-126.
15. YAMAMOTO T, ENDO A, INAGI Y, OHMORI T, NAKAIWA M: Evaluation of thermoporometry for characterisation of mesoporous materials. J. Colloid Interface Sci. (2005) 284(2):614-620.
16. TSUBOI T, SAKKA T, OGATA YH: Structural study of porous silicon and its oxidized states by solid state high resolution 29Si NMR spectroscopy. Phys. Rev. B (1998) 58(20):13863-13869.
17. ANDERSON SHC, ELLIOTT H, WALLIS DJ, CANHAM LT, POWELL JJ: Dissolution of different forms of partially porous silicon wafers under simulated physiological conditions. Physica Status Solidi (A): Applied Research (2003) 197(2):331-335.
18. CANHAM L: Predicted biodegradability of mesoporous silicon in various sites of the human body. In: Porous Semiconductors -Science and Technology. Cullera-Valencia, Spain (2004) 044:102-103.
19. REFITT DM, JUGDAOHSINGH R, THOMPSON RP, POWELL JJ: Silicic acid: its gastrointestinal uptake and urinary excretion in man and effects on aluminium excretion. J. Inorg. Biochem. (1999) 76:141-147.
20. ILER RK: In: The chemistry of silica: solubility, polymerization, colloid and surface properties and biochemistry. J.Wiley & Sons (1979): 195-202.
21. 32Si and accelerator mass spectrometry. J. Inorg. Biochem. (1998) 69(3):177-180.
22. SRIPANYAKORN S, JUGADAOSHSING R, ELLIOTT H et al.: The silicon content of beer and its bioavailability in healthy volunteers. Br. J. Nutr. (2004) 91:403-409.
23. WROBEL K, BLANCO GONZALEZ E, SANZ-MEDEL A: Progress with the speciation of aluminium and silicon in serum of chronic renal patients using atomic spectroscopic techniques J. Anal. Atom. Spectrom. (1994) 9:281-284.
24. DOBBIE JW, SMITH MJB: In: Silicon Biochemistry Evered D, O'Connor M (Eds) Wiley & Sons (1986) 26:194-213.
25. BISSI E, EPTING T, BEIL A, LINDINGER G, LANG H, WIELAND H: Reference values for serum silicon in adults. Anal. Biochem. (2005) 337:130-135.
26. ROSENGREN A, WALLMAN L, BENGTSSON M, LAURELL TH, DANIELSEN N, BJURTSEN LM: Tissue reactions to porous silicon: a comparative biomaterial study. Physica Status Solidi (A): Applied Research (2000) 182:527-531.
27. PETROVA EA, BOGOSLOVSKAYA KN, BALAGUROV LA, KOCHORADZE GI et al.: Room temperature oxidation of porous silicon in air. materials Science and Engineering (2000) B69/B70:152-156.
28. BURIAK JM, STEWART MP, GEDERS TW et al.: Lewis acid mediated hydrosilylation on porous silicon surfaces J. Am. Chem. Soc. (1999) 121:11491-11502.
29. BOUKHERROUB R, WAYNER DDM, LOCKWOOD DJ, CANHAM LT: Passivated luminescent porous silicon. J. Electrochem. Soc. (2001) 148(9):H91-H97.
30. MATTEI G, VALENTINI V: In Situ Functionalization of Porous Silicon during the Electrochemical Formation Process in Ethanoic Hydrofluoric Acid Solution. J. Electrochem. Soc. (2003) 125:9608-9609.
31. LOW SP, WILLIAMS KA, CANHAM LT, VOELCKER NH: Evaluation of mammalian cell adhesion on surface-modified porous silicon. Biomaterials (2006) 27:4538-4546.
32. SONG JH, SAILOR MJ: Chemical modifications of Crystalline Porous Silicon Surfaces. Comments on Inorganic Chemistry (1999) 21(1-3):69-84.
33. BURIAK JM: Organomet allic chemistry on silicon and germanium surfaces. Chem. Rev. (2002) 102:1271-1308.
34. VASANTH KUMAR K, SIVANESAN S: Equilibrium data, isotherm parameters and process design for partial and complete isotherm of methylene blue onto activated carbon. J. Hazard. Mater. (20O6) 134:237-244.
35. LIPINSKI C: Poor aqueous solubility - an industry wide problem in drug discovery. Am. Pharm Rev. (2002) 5:82-85.
36. LEUNER C, DRESSMAN J: Improving drug solubility for oral drug delivery using solid dispersions. Eur. J. Pharm. Biopharm. (2000) 50:47-60.
37. MERISKO-LIVERSAGE E, LIVERSAGE GG, COOPER ER: Nanosizing a formulation approach for poorly water soluble compounds. Eur. J. Pharm. Biopharm. (2003) 18:113-120.
38. SINGH M, SHARMA R, BANDERJEE UC: Biotechnological applications of cyclodextrins. Biotechnol. Adv. (2002) 20:341-359.
39. HU J, JOHNSTON KP, WILLIAMS III RO: Spray freeze drying into liquid (SFL) particle engineering technology to enhance dissolution of poorly water soluble drugs: organic solvent versus organic/aqueous co-solvent systems. Eur. J. Pharm. Sci. (2003) 20:295-303.
40. GINTY PJ, WHITAKER MJ, SHAKESHEFF KM, HOWDLE SM: Drug delivery goes supercritical. materials Today (2005) 8(1):42-48.
41. POUTON CW: Formulation of poorly water-soluble drugs for oral administration: Physiochemical and physiological issues and the lipid formulation classification system. Eur. J. Pharm. Sci. (2006) 29(3-4):278-287.
42. LEHTO V-P, VÄHÄ-HEIKKILÄ K, PASKI J, SALONEN J: Use of thermoanalytical methods in quantification of drug load in mesoporous silicon microparticles. Journal of Thermal Analysis and Calorimetry (2005) 80(2):393-397.
43. LAU CH, TOTOLICI M, BARNETT C: Enhanced dissolution of poorly soluble drugs using mesoporous silicon. AAPS PharmSci. (2006) W4143.
44. SHABIR QA, LÄU CH, YANG HL, SAFFIE RS, CANHAM LT: Enhanced dissolution kinetics of poorly soluble drugs using mesoporous silicon. In: Porous Semiconductors - Science and Technology. Stiges, Spain (2006): 2-58.
45. SALONEN J, LAITINEN L, KAUKONEN AM et al.: Mesoporous silicon microparticles for oral drug delivery: loading and release of five model drugs. J. Control. Release. (2005) 108:362-374.
46. BULPITT P, CONNOR SE: Improved bioavailability of cyclosporine A using porous silicon: single dose pharmacokinetic study in the rat. Proceedings of the 33rd Annual Meeting and Exposition of the Controlled Release Society. Vienna, Austria (2006) 849.
47. BIRNBAUM DT, BRANNON-PEPPAS L: Microparticle drug delivery systems. In: Drug Delivery Systems in Cancer Therapy Brown DM (Ed.) Humana Press inc., Totowa, NJ (2003):117-136.
48. VICCARI L, CANTON D, ZAFFARONI N, VILLA R, TORMEN M, DI FABRIZIO E: Porous silicon as a drug carrier for controlled delivery of doxorubicin anticancer agent. Microelectronic Engineering (2006) 83:1598-1601.
49. SAFFIE-SIEBERT RS, DRAGE D, TORABI-POUR N et al: Application of BioSilicon in drug delivery and drug targeting: Intratumoral therapy. AAPS J. (2004) 6(4) Abstr. W5245.
50. ANGLIN EJ, SCHWARTZ MP, NG VP, PERELMAN LA, SAILOR MJ: Engineering the chemistry and nanostructure of porous silicon Fabry-Pérot films for loading and release of a steroid. Langmuir (2004) 20:11264-11269.
51. SINHA VR, TREHAN A: Biodegradable microspheres for protein delivery. J. Control Release. (2003) 90:261-280.
52. SHABIR QA, LAU CH, TOTOLICI M, SAFFIE RS, CANHAM LT: Porous silicon technology for controlled release of highly soluble compounds: Pilot study for a model peptide. In: Porous Semiconductors - Science and Technology. Stiges, Spain (2006):2-56.
53. FORAKER AB, WALCZAK RJ, COHEN MH, BOIARSKI TA, GROVE CF, SWAAN PW: Microfabricated Porous Silicon Particles Enhance Paracellular Delivery of Insulin Across Intestinal Caco-2 Cell Monolayers. Pharm. Res. (2003) 20(1):110-116.
54. KARLSSON LM, TENGVALL P, LUNDSTROM I, ARWIN H: Penetration and loading of human serum albumin in porous silicon layers with different pore sizes and thicknesses. J. Colloid Interface Sci. (2003) 266(1):40-47.
55. RUSO JM, TABOADA P, VARELA LM, ATTWOOD D, MOSQUERA V: Adsorption of an amphiphilic penicillin onto human serum albumin: Characterisation of the complex. Biophys. Chem. (2001) 92:141-153.
56. PRESTIDGE CA, BARNES TJ, MIERCZYNSKA-VASILEV A et al.: Peptide and protein loading into porous silicon wafers. Physica Status Solidi (A): Applied Research (2007) (in press). Mechanisms behind protein and peptide loading in porous silicon.
57. PRESTIDGE CA, BARNES TJ, MIERCZYNSKA-VASILEV A, SKINNER W, PEDDIE F, LAU CH, BARNETT C: Loading and release of a model protein from porous silicon powders. Phys. Stat. Sol A (2007) (In press).
58. TAKEUCHI H, NAGIRA S, YAMAMOTO H, KAWASHIMA Y: Solid dispersion particles of amorphous indomethacin with fine porous silica particles by using spray-drying method. Int. J. Pharm. (2005) 293:155-164.
59. DEGUSSA AG: Technical bulletin Fine Particles (No. 11), Company Publication, Frankfurt, Germany, 4th edition (2006).
60. MONKHOUSE DC, LACK JL: Use of adsorbents in enhancement of drug dissolution I. J. Phar M. Sci. (1972) 61(9):1430-1435
61. FRIEDRICH H, FUSSNEGGER B, KOLTER K, BODMEIER R: Dissolution rate improvement of poorly water soluble drugs obtained by adsorbing solutions of drugs in hydrophilic solvents onto high surface area carriers. Eur. J. Pharm. Biopharm. (2006) 62:171-177.
62. SMIRNOVA I, SUTTIRUENGWONG S, ARLT W: Feasibility study of hydrophilic and hydrophobic silica aerogels as drug delivery systems. Journal of Non-Crystalline Solids (2004) 350:54-60.
63. SANTINI J.T, RICHARDS AC, SCHEIDT R, CIMA MJ, LANGER R: Microchips as controlled drug-delivery devices. Angewandte Chemie (2000) 39(14):2396-2407.
64. LEONG WY, LONI A, CANHAM LT: Electrically enhanced erosion of porous silicon in electrolyte by pH modulation. Physica Status Solidi (A): Applied Research (2007) (In press).
65. REDFERN P: Chapter 11. In: Chronotherapeutics. Pharmaceutical Press, UK (2003).
66. PRAUSNITZ MR, MITRAGOTRI S, LANGER R: Current status and future potential of transdermal drug delivery. Nat. Rev. Drug Discov. (2004) 3:115-124.